LAB
Standard BioTools Inc.
Company Overview
| Mkt Cap | $534.79M | Price | $1.20 |
| Volume | 1.57M | Change | +4.35% |
| P/E Ratio | -3.9 | Open | $1.14 |
| Revenue | $174.4M | Prev Close | $1.15 |
| Net Income | $-138.9M | 52W Range | $0.92 - $2.32 |
| Div Yield | N/A | Target | $1.78 |
| Overall | 47 | Value | 60 |
| Quality | 55 | Technical | 27 |
No chart data available
Stock Overview
Updated DailyStandard BioTools Inc. (LAB) is a leading diversified company in the business industry, currently trading at $1.20 with a market capitalization of $534.79 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows LAB with a volume of 1.57 million shares. The stock opened down 0.87% from yesterday's close of $1.15. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
LAB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for LAB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 48.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 08:22 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LAB | $1.20 | +4.3% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |